Kate Hermans
CBO Pharma

Kate Hermans is a global, innovative leader known for her effective, and incisive ability to grow emerging and mature businesses. She has a proven track record of bridging digital technology to biopharma, building and leading small, agile teams to drive exceptional financial outcomes.

Currently Kate is the Chief Business Officer (Pharma) for 83bar LLC, which has developed a fully integrated digital health technology and concierge platform that enables individualized patient activation at scale. The 83bar platform has been implemented by more than 25 Life Sciences clients, across a wide array of disease areas (rare, genetic, chronic), nearly 900,000 patient engagements, and with an average ROI of 7:1.

Prior to joining 83bar, Kate held roles of increasing responsibility at Radius Health, Bristol-Myers Squibb, Pfizer, Wyeth, Intel, as well as start-ups, working in the U.S., China, Africa, and in Global roles. In her Pharma roles, Kate was best known for building, fixing, or growing businesses. For example, Kate led the global turnaround of 10-year old Orencia® in less than 7 months with a team of 4 and a limited budget, which resulted in 15-20% annual growth and a doubling of global sales in four years.

She serves as a Digital Health-Tech Advisor to national and regional accelerators (e.g. DreamIt, Ben Franklin Tech Partners). Kate also serves as an Advisor to women-owned start-ups and sits on the Advisory Board of the Women’s Resource Center.

Kate received her Master’s degree in Finance and International Management from the Thunderbird School of Global Management, as well as a BA in International Relations from Wheaton College, MA.